Literature DB >> 4136593

Clinical cardiovascular pharmacology of dobutamine. A selective inotropic catecholamine.

D Jewitt, J Birkhead, A Mitchell, C Dollery.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1974        PMID: 4136593     DOI: 10.1016/s0140-6736(74)91754-1

Source DB:  PubMed          Journal:  Lancet        ISSN: 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  23 in total

1.  Electromechanical interrelations during dobutamine stress in normal subjects and patients with coronary artery disease: comparison of changes in activation and inotropic state.

Authors:  A M Duncan; C A O'Sullivan; D G Gibson; M Y Henein
Journal:  Heart       Date:  2001-04       Impact factor: 5.994

2.  Comparative haemodynamic effects of dobutamine and isoproterenol in man.

Authors:  M Rigaud; J Boschat; P Rocha; A Ferreira; J Bardet; J P Bourdarias
Journal:  Intensive Care Med       Date:  1977-08       Impact factor: 17.440

3.  Long-lived ames dwarf mice are resistant to chemical stressors.

Authors:  Alex F Bokov; Merry L Lindsey; Christina Khodr; Marian R Sabia; Arlan Richardson
Journal:  J Gerontol A Biol Sci Med Sci       Date:  2009-05-04       Impact factor: 6.053

4.  Cardiovascular effects of a new inotropic agent, U. K. 14275, in patients with coronary heart disease.

Authors:  I Hutton; W S Hillis; C E Langhan; J M Conely; T D Lawrie
Journal:  Br J Clin Pharmacol       Date:  1977-10       Impact factor: 4.335

5.  Bretylium and dobutamine in the treatment of coronary artery disease.

Authors:  W H Frishman
Journal:  Bull N Y Acad Med       Date:  1979-09

6.  [Cardiovascular effects of dobutamine (author's transl)].

Authors:  P Limbourg; H Just; F Kersting; K F Lang
Journal:  Klin Wochenschr       Date:  1978-06-01

7.  The inotropic effects of UK 14,275, a phosphodiesterase inhibitor, in man.

Authors:  P G Jackson; G Jackson; D Kitson; D E Jewitt
Journal:  Br J Clin Pharmacol       Date:  1978-01       Impact factor: 4.335

8.  Dobutamine, isoprenaline and dopamine in patients after open heart surgery.

Authors:  J H Chamberlain; J R Pepper; A K Yates
Journal:  Intensive Care Med       Date:  1980-11       Impact factor: 17.440

9.  The use of dobutamine in myocardial infarction for reversal of the cardiodepressive effect of metoprolol.

Authors:  F Waagstein; I Malek; A C Hjalmarson
Journal:  Br J Clin Pharmacol       Date:  1978-06       Impact factor: 4.335

10.  Dobutamine in the treatment of depressed cardiac function: a study in patients with ischaemic heart disease during the early post-operative period.

Authors:  M Pinaud; P Desjars; F Nicolas
Journal:  Intensive Care Med       Date:  1978-04       Impact factor: 17.440

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.